TABLE 3.
Assay and drug | No. of levels measured | Concn range (μg/ml) | Median quantifiable concn (μg/ml) | % of measurements below LLQa | % of measurements below 0.5 μg/ml | % of measurements above 17.1 μg/ml | Median matched hydroxyitraconazole/itraconazole ratio (range) |
---|---|---|---|---|---|---|---|
UPLC/MS | |||||||
Itraconazole | 689 | Undetectable–7.37 | 0.84 | 38 | 54.60 | 1.59 (0.2–3.63) | |
Hydroxyitraconazole | 676 | Undetectable–7.31 | 1.13 | 25.30 | |||
Itraconazole + hydroxyitraconazole | 651 | Undetectable–14.01 | 1.71 | 26.30 | 42.40 | ||
Bioassay | |||||||
Itraconazole/hydroxyitraconazole | 3,105 | Undetectable–>20 | 4.75 | 18 | 3.00 |
The lower limit of quantification (LLQ) was <0.25 μg/ml for UPLC/MS and <0.5 μg/ml for bioassay.